Generics

Q&A: Accord Healthcare’s Jeff Hampton highlights the generics supplier’s expertise
Accord Healthcare's president talked to DSN about the state of the generics industry and how his company differentiates itself in a crowded and increasingly complex field.
Zydus Cadila receives FDA nod for generic Rythmol
Zydus Cadila's generic Rythmol capsules work by blocking the activity of certain electrical signals in the heart that can cause an irregular heartbeat.

Reintroduction of BIOSIM Act garners trade group’s praise

The Biosimilars Council applauds Reps. Kurt Schrader (D-Ore.) and Adam Kinzinger (R-Ill.) for fighting to expand patient access to affordable drugs.
AAM Biosimilars Council applauds Biden for signing biosimilar law

The Advancing Education on Biosimilars Act of 2021 authorizes the Food and Drug Administration to educate consumers and healthcare providers on the benefits of biosimilar medications.
Alembic obtains FDA green light for generic Sinequan

Doxepin hydrochloride capsules had a market value of $41 million for the 12 months ended December 2020, according to IQVIA.
MSN/Novadoz intros 4 generics

Novadoz has commenced shipping of generic versions of Albenza, Northera, Jadenu Sprinkles and Lyrica.
Camber debuts generic Bloxiverz

Camber's generic Bloxiverz is used to reverse the effects of anesthesia medications used during surgery.
Hikma resumes launch of generic Advair Diskus

Hikma will immediately resume launch activities of generic Advair Diskus in 100 mcg/50 mcg and 250 mcg/50 mcg dosage strengths.
State of the Pharmacy 2021: Executives weigh in

Executives from leading pharmaceutical and technology and automation companies size up the pharmacy space as we move into the second year of the pandemic and pharmacies continue to play a crucial role in COVID-19 vaccinations.
Fresenius Kabi taps Sandoz’s Pawlu to head generics, complex formulations

Fresenius Kabi has tapped former Sandoz executive Christian Pawlu to lead generics and complex unit formulations.

Q&A: Accord Healthcare’s Jeff Hampton highlights the generics supplier’s expertise

Zydus Cadila receives FDA nod for generic Rythmol

Reintroduction of BIOSIM Act garners trade group’s praise

AAM Biosimilars Council applauds Biden for signing biosimilar law

Alembic obtains FDA green light for generic Sinequan

MSN/Novadoz intros 4 generics

Camber debuts generic Bloxiverz

Hikma resumes launch of generic Advair Diskus

State of the Pharmacy 2021: Executives weigh in

Fresenius Kabi taps Sandoz’s Pawlu to head generics, complex formulations